Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats

Psychopharmacology ◽

10.1007/s00213-002-1111-5 ◽

2002 ◽

Vol 162 (3) ◽

pp. 323-332 ◽

Author(s):

Daisuke Mochizuki ◽

Ryuichi Tsujita ◽

Shinji Yamada ◽

Koh Kawasaki ◽

Yuji Otsuka ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Synthesis, crystal structure analysis, and pharmacological characterization of desmethoxy-sila-venlafaxine, a derivative of the serotonin/noradrenaline reuptake inhibitor sila-venlafaxine

Journal of Organometallic Chemistry ◽

10.1016/j.jorganchem.2006.04.015 ◽

2006 ◽

Vol 691 (17) ◽

pp. 3589-3595 ◽

Author(s):

Jürgen O. Daiß ◽

Christian Burschka ◽

John S. Mills ◽

John G. Montana ◽

Graham A. Showell ◽

...

Keyword(s):

Crystal Structure ◽

Structure Analysis ◽

Reuptake Inhibitor ◽

Crystal Structure Analysis ◽

Pharmacological Characterization ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.118.248351 ◽

2018 ◽

Vol 365 (3) ◽

pp. 624-635 ◽

Author(s):

Xiangqing Xu ◽

Yaqin Wei ◽

Qiang Guo ◽

Song Zhao ◽

Zhiqiang Liu ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Antagonist Activity ◽

Pharmacological Characterization ◽

Noradrenaline Reuptake ◽

Treatment Of Depression ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Faculty Opinions recommendation of Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058908.509706 ◽

2007 ◽

Author(s):

Paul Hilton

Keyword(s):

Systematic Review ◽

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.4.7.1165 ◽

2003 ◽

Vol 4 (7) ◽

pp. 1165-1174 ◽

Author(s):

Christopher J Kratochvil ◽

Brigette S Vaughan ◽

Martin J Harrington ◽

William J Burke

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Reuptake Inhibitor ◽

Attention Deficit ◽

Hyperactivity Disorder ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

(R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/j.bmcl.2005.12.062 ◽

2006 ◽

Vol 16 (9) ◽

pp. 2555-2558 ◽

Author(s):

Graham A. Showell ◽

Matthew J. Barnes ◽

Jürgen O. Daiss ◽

John S. Mills ◽

John G. Montana ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

The effect of serotonin–noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats

European Spine Journal ◽

10.1007/s00586-015-4239-9 ◽

2015 ◽

Vol 25 (3) ◽

pp. 877-887 ◽

Author(s):

Junichi Handa ◽

Miho Sekiguchi ◽

Olga Krupkova ◽

Shin-ichi Konno

Keyword(s):

Reuptake Inhibitor ◽

Intervertebral Disk ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Serotonin and noradrenaline reuptake inhibitor duloxetine reduces daily off time in Parkinson’s disease

Journal of the Neurological Sciences ◽

10.1016/j.jns.2015.08.1012 ◽

2015 ◽

Vol 357 ◽

pp. e291

Author(s):

M. Tomiyama ◽

Y. Funamizu ◽

T. Kon ◽

T. Ueno ◽

H. Nishijima ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Off Time ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

International Journal of Urology ◽

10.1111/iju.14411 ◽

2020 ◽

Author(s):

Satoru Takahashi ◽

Kumiko Kato ◽

Mineo Takei ◽

Osamu Yokoyama ◽

Momokazu Gotoh

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Reuptake Inhibitor ◽

Early Phase ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor

Neuroscience Letters ◽

10.1016/j.neulet.2013.02.076 ◽

2013 ◽

Vol 544 ◽

pp. 68-73 ◽

Author(s):

Rui Xue ◽

Yan-Ping Zhang ◽

Zeng-Liang Jin ◽

Li Yuan ◽

Xin-Hua He ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text

Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine: Synthesis, Crystal Structure Analysis, and Pharmacological Characterization

Organometallics ◽

10.1021/om058051y ◽

2006 ◽

Vol 25 (5) ◽

pp. 1188-1198 ◽

Author(s):

Jürgen O. Daiss ◽

Christian Burschka ◽

John S. Mills ◽

John G. Montana ◽

Graham A. Showell ◽

...

Keyword(s):

Crystal Structure ◽

Structure Analysis ◽

Reuptake Inhibitor ◽

Crystal Structure Analysis ◽

Pharmacological Characterization ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text